alexa
Reach Us +44-176-4910199
Crohn?s Disease And Treatment Modalities | 3339
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Crohn?s disease and treatment modalities

2nd International Conference on Gastroenterology & Urology

Sachin Manthuruthil

ScientificTracks Abstracts: J Gastrointest Dig Syst

DOI: 10.4172/2161-069X.S1.012

Abstract
Crohn?s disease is an inflammatory bowel disease having multiple gastrointestinal and systemic manifestations by way of its inflammatory and genetic pathogenic mechanism. The entire gastrointestinal tract may be affected by Crohn?s, affected areas determining symptomatology and manifestation signs. Prevalence rates are reported as 43 per 100,000 in those under age 20, and 201 per 100,000 in adults. Diarrhea, abdominal pain often right lower quadrant, cachexia, nutritional deficiencies and extra- intestinal manifestations ie. arthritis, skin manifestations including erythema nodosum, gallstones, kidney stones have been observed. Standard diagnostic method includes colonoscopy with biopsy however there is no single gold standard for diagnosis. Clinical evaluation and a combination of endoscopic findings, histology, radiologic findings and laboratory investigations must all be considered. Medical and Surgical treatment options exist, both enhanced by dedicated lifestyle modification, an element commonly underused. Medical treatment objective tends towards infection control with antimicrobial agents and control of inflammatory processes. Commonly anti-inflammatories are sulfasalazine, mesalamine, olsalazine, balsalazide. Tolerance of such agents is variable but generally good. Systemic corticosteroids administration also may be used. Probiotics are reported to offer benefit as well. Other drug types used in may be immunomodulators ie. azathioprine,methotrexate, cyclosporine. Bowel rest and enteral feeding are used during acute flares. Research demonstrates Tumor Necrosis Factor in a crucial role in Crohn's inflammation thus treatment with anti-TNF drugs ie. infliximab, adalimumab are seen to benefit. Some clinical trial suggest that Crohn's patients treated with TNF-alpha inhibitors can reach and maintain remission. Surgery is indicated only in severe forms of disease and when there are complications like stricture formation, obstruction or fistula formation. Commonly performed surgeries are strictureplasty resection & anastomosis, Colectomy, Proctocolectomy, and Ileostomy.
Biography
Sachin Manthuruthil is a graduate of Sri Ramachandra University of Chennai, Tamil Nadu. He aspires to do his residency training and be a practicing clinician in the USA.
Top